feed,title,long_url,short_url
Benzinga,Clene's Amyotrophic Lateral Sclerosis Candidate Disappoints In Mid-Stage Study,https://benzinga.com/general/biotech/21/11/23818491/clenes-amyotrophic-lateral-sclerosis-candidate-disappoints-in-mid-stage-study,https://j.mp/2Y8yBnE
Benzinga,51 Stocks Moving In Tuesday's Mid-Day Session,https://benzinga.com/news/21/11/23830492/51-stocks-moving-in-tuesdays-mid-day-session,https://j.mp/3BELHqD
